Skip to main content
SpringerLink
Log in

MRI and MRCP

  • Chapter
  • First Online:
Imaging Diagnostics in Pancreatic Cancer

Part of the book series: Clinical Gastroenterology ((CG))

  • 392 Accesses

Abstract

With continued advancement in resolution and imaging techniques, magnetic resonance imaging (MRI) has become one of the main diagnostic and staging tools for pancreatic adenocarcinoma. High soft tissue contrast and sensitivity for detecting lymph node, liver, vascular, or peritoneal involvement of the disease makes MRI an ideal imaging tool for surgical and treatment planning. In this chapter, MRI techniques and MRI characteristics of pancreatic adenocarcinoma will be introduced.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

CT:

Computed tomography

DWI:

Diffusion-weighted imaging

MIP:

Maximal intensity projection

MRCP:

Magnetic resonance cholangiopancreatography

MRI:

Magnetic resonance imaging

(1.5 or 3) T:

Tesla

References

  1. Grover VP, Tognarelli JM, Crossey MM, Cox IJ, Taylor-Robinson SD, McPhail MJ. Magnetic resonance imaging: principles and techniques: lessons for clinicians. J Clin Exp Hepatol. 2015;5(3):246–55.

    Article  Google Scholar 

  2. De Robertis R, Tinazzi Martini P, Demozzi E, Dal Corso F, Bassi C, Pederzoli P, et al. Diffusion-weighted imaging of pancreatic cancer. World J Radiol. 2015;7(10):319–28.

    Article  Google Scholar 

  3. Scialpi M, Reginelli A, D’Andrea A, Gravante S, Falcone G, Baccari P, et al. Pancreatic tumors imaging: an update. Int J Surg. 2016;28(Suppl 1):S142–55.

    Article  Google Scholar 

  4. Kim SY, Byun JH, Lee SS, Park SH, Jang YJ, Lee MG. Biliary tract depiction in living potential liver donors: intraindividual comparison of MR cholangiography at 3.0 and 1.5 T. Radiology. 2010;254(2):469–78.

    Article  Google Scholar 

  5. Schmidt GP, Wintersperger B, Graser A, Baur-Melnyk A, Reiser MF, Schoenberg SO. High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study. Investig Radiol. 2007;42(6):449–59.

    Article  Google Scholar 

  6. Goncalves Neto JA, Altun E, Elazzazi M, Vaidean GD, Chaney M, Semelka RC. Enhancement of abdominal organs on hepatic arterial phase: quantitative comparison between 1.5- and 3.0-T magnetic resonance imaging. Magn Reson Imaging. 2010;28(1):47–55.

    Article  Google Scholar 

  7. Kanal E, Barkovich AJ, Bell C, Borgstede JP, Bradley WG, Froelich JW, et al. ACR guidance document on MR safe practices: 2013. J Magn Reson Imaging. 2013;37(3):501–30.

    Article  Google Scholar 

  8. Dewey M, Schink T, Dewey CF. Claustrophobia during magnetic resonance imaging: cohort study in over 55,000 patients. J Magn Reson Imaging. 2007;26(5):1322–7.

    Article  Google Scholar 

  9. Munn Z, Jordan Z. Interventions to reduce anxiety, distress and the need for sedation in adult patients undergoing magnetic resonance imaging: a systematic review. Int J Evid Based Healthc. 2013;11(4):265–74.

    Article  Google Scholar 

  10. Qayyum A, Tamm EP, Kamel IR, Allen PJ, Arif-Tiwari H, Chernyak V, et al. ACR appropriateness criteria. J Am Coll Radiol. 2017;14(11S):S560–S9.

    Article  Google Scholar 

  11. Koelblinger C, Ba-Ssalamah A, Goetzinger P, Puchner S, Weber M, Sahora K, et al. Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: prospective evaluation in patients suspected of having pancreatic cancer. Radiology. 2011;259(3):757–66.

    Article  Google Scholar 

  12. Zhang Y, Huang J, Chen M, Jiao LR. Preoperative vascular evaluation with computed tomography and magnetic resonance imaging for pancreatic cancer: a meta-analysis. Pancreatology. 2012;12(3):227–33.

    Article  Google Scholar 

  13. Motosugi U, Ichikawa T, Morisaka H, Sou H, Muhi A, Kimura K, et al. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT. Radiology. 2011;260(2):446–53.

    Article  Google Scholar 

  14. Khorana AA, McKernin SE, Katz MHG. Potentially curable pancreatic adenocarcinoma: ASCO clinical practice guideline update summary. J Oncol Pract. 2019;15(8):454–7.

    Article  Google Scholar 

  15. National Comprehensive Cancer Network. Pancreatic adenocarcinoma (Version 3.2019). Available from: https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf.

  16. Lee ES, Lee JM. Imaging diagnosis of pancreatic cancer: a state-of-the-art review. World J Gastroenterol. 2014;20(24):7864–77.

    Article  Google Scholar 

  17. Miller FH, Rini NJ, Keppke AL. MRI of adenocarcinoma of the pancreas. AJR Am J Roentgenol. 2006;187(4):W365–74.

    Article  Google Scholar 

  18. Manikkavasakar S, AlObaidy M, Busireddy KK, Ramalho M, Nilmini V, Alagiyawanna M, et al. Magnetic resonance imaging of pancreatitis: an update. World J Gastroenterol. 2014;20(40):14760–77.

    Article  Google Scholar 

  19. Krishnamurthy S, Balasubramaniam R. Role of imaging in peritoneal surface malignancies. Indian J Surg Oncol. 2016;7(4):441–52.

    Article  Google Scholar 

  20. Yeh R, Dercle L, Garg I, Wang ZJ, Hough DM, Goenka AH. The role of 18F-FDG PET/CT and PET/MRI in pancreatic ductal adenocarcinoma. Abdom Radiol (NY). 2018;43(2):415–34.

    Article  Google Scholar 

  21. Salamon N, Kung J, Shaw SJ, Koo J, Koh S, Wu JY, et al. FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy. Neurology. 2008;71(20):1594–601.

    Article  CAS  Google Scholar 

  22. Romeo V, Iorio B, Mesolella M, Ugga L, Verde F, Nicolai E, et al. Simultaneous PET/MRI in assessing the response to chemo/radiotherapy in head and neck carcinoma: initial experience. Med Oncol. 2018;35(7):112.

    Article  Google Scholar 

  23. Heusch P, Buchbender C, Köhler J, Nensa F, Beiderwellen K, Kühl H, et al. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results. Rofo. 2013;185(11):1056–62.

    Article  CAS  Google Scholar 

  24. Kang B, Lee JM, Song YS, Woo S, Hur BY, Jeon JH, et al. Added value of integrated whole-body PET/MRI for evaluation of colorectal cancer: comparison with contrast-enhanced MDCT. AJR Am J Roentgenol. 2016;206(1):W10–20.

    Article  Google Scholar 

  25. Barbaro B, Vitale R, Leccisotti L, Vecchio FM, Santoro L, Valentini V, et al. Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. Radiographics. 2010;30(3):699–716.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Maryland Medical Center, Department of Diagnostic Radiology and Nuclear Medicine, Baltimore, MD, USA

    Il Kyoon Kim & Barton F. Lane

Authors
  1. Il Kyoon Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barton F. Lane
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Il Kyoon Kim .

Editor information

Editors and Affiliations

  1. Division of Gastroenterology and Hepatology, Norwalk Hospital, Nuvance Health, Norwalk, CT, USA

    Naveen Anand

  2. Division of Gastroenterology and Hepatology, University of Maryland School of Medicine, Baltimore, MD, USA

    Peter Darwin

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kim, I.K., Lane, B.F. (2021). MRI and MRCP. In: Anand, N., Darwin, P. (eds) Imaging Diagnostics in Pancreatic Cancer. Clinical Gastroenterology. Humana, Cham. https://doi.org/10.1007/978-3-030-69940-6_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-69940-6_2

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-69939-0

  • Online ISBN: 978-3-030-69940-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation